p300 transcriptional repression is mediated by SUMO modification

Molecular Cell

Volumn 11, Issue 4, 2003, Pages 1043-1054

  Girdwood, David ^a   Bumpass, Donna ^b   Vaughan, Owen A ^a   Thain, Alison ^b   Anderson, Lisa A ^b   Snowden, Andrew W ^b   Garcia Wilson, Elisa ^b   Perkins, Neil D ^b   Hay, Ronald T ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE DEACETYLASE; PROTEIN; PROTEIN CYCLE REGULATORY DOMAIN 1; PROTEIN P300; PROTEINASE; SUMO 1 PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONJUGATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MUTATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0037961625     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00141-2     Document Type: Article

References (47)

1. Ait-Si-Ali S., Polesskaya A., Filleur S., Ferreira R., Duquet A., Robin P., Vervish A., Trouche D., Cabon F., Harel-Bellan A. CBP/p300 histone acetyl-transferase activity is important for the G1/S transition. Oncogene. 19:2000;2430-2437.
2. Bernier-Villamor V., Sampson D.A., Matunis M.J., Lima C.D. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell. 108:2002;345-356.
3. Best J.L., Ganiatsas S., Agarwal S., Changou A., Salomoni P., Shirihai O., Meluh P.B., Pandolfi P.P., Zon L.I. SUMO-1 protease-1 regulates gene transcription through PML Mol. Cell. 10:2002;843-855.
4. Bies J., Markus J., Wolff L. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J. Biol. Chem. 277:2002;8999-9009.
5. Boisvert F.M., Hendzel M.J., Bazett-Jones D.P. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148:2000;283-292.
6. Boisvert F.M., Kruhlak M.J., Box A.K., Hendzel M.J., Bazett-Jones D.P. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J. Cell Biol. 152:2001;1099-1106.
7. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
8. Chang B.D., Watanabe K., Broude E.V., Fang J., Poole J.C., Kalinichenko T.V., Roninson I.B. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression. implications for carcinogenesis, senescence, and age-related diseases Proc. Natl. Acad. Sci. USA. 97:2000;4291-4296.
9. David G., Neptune M.A., DePinho R.A. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277:2002;23658-23663.
10. Desterro J.M., Thomson J., Hay R.T. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417:1997;297-300.
11. Desterro J.M., Rodriguez M.S., Hay R.T. SUMO-1 modification of IκBα inhibits NF-kappaB activation. Mol. Cell. 2:1998;233-239.
12. Doucas V., Tini M., Egan D.A., Evans R.M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. USA. 96:1999;2627-2632.
13. Goodman R.H., Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:2000;1553-1577.
14. Gregory D.J., Garcia-Wilson E., Poole J.C., Snowden A.W., Roninson I.B., Perkins N.D. Induction of transcription through the p300 CRD1 motif by p21 (WAF1/CIP1) is core promoter specific and cyclin dependent kinase independent. Cell Cycle. 1:2002;343-350.
15. Hang J., Dasso M. Association of the Human SUMO-1 Protease SENP2 with the Nuclear Pore. J. Biol. Chem. 277:2002;19961-19966.
16. Hay R.T. Protein modification by SUMO. Trends Biochem. Sci. 26:2001;332-333.
17. Hook, S.S., Orian, A., Cowley, S.M., and Eisenman, R.N. (2002). Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc. Natl. Acad. Sci. USA.
18. Jackson P.K. A new RING for SUMO. wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases Genes Dev. 15:2001;3053-3058.
19. Johnson E.S., Gupta A.A. An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell. 106:2001;735-744.
20. Kadoya T., Yamamoto H., Suzuki T., Yukita A., Fukui A., Michiue T., Asahara T., Tanaka K., Asashima M., Kikuchi A. Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of β-catenin. Mol. Cell. Biol. 22:2002;3803-3819.
21. Kahyo T., Nishida T., Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell. 8:2001;713-718.
22. Khochbin S., Verdel A., Lemercier C., Seigneurin-Berny D. Functional significance of histone deacetylase diversity. Curr. Opin. Genet. Dev. 11:2001;162-166.
23. Kirsh O., Seeler J.S., Pichler A., Gast A., Muller S., Miska E., Mathieu M., Harel-Bellan A., Kouzarides T., Melchior F., Dejean A. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21:2002;2682-2691.
24. Kung A.L., Rebel V.I., Bronson R.T., Ch'ng L.E., Sieff C.A., Livingston D.M., Yao T.P. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14:2000;272-277.
25. LaMorte V.J., Dyck J.A., Ochs R.L., Evans R.M. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA. 95:1998;4991-4996.
26. Lin D., Tatham M.H., Yu B., Kim S., Hay R.T., Chen Y. Identification of a substrate recognition site on ubc9. J. Biol. Chem. 277:2002;21740-21748.
27. Newton A.L., Sharpe B.K., Kwan A., Mackay J.P., Crossley M. The transactivation domain within cysteine/histidine-rich region 1 of CBP comprises two novel zinc-binding modules. J. Biol. Chem. 275:2000;15128-15134.
28. Nishida T., Kaneko F., Kitagawa M., Yasuda H. Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat Axam, which is an Axin-binding protein promoting beta-catenin degradation. J. Biol. Chem. 276:2001;39060-39066.
29. Perkins N.D. Not Just a CDK Inhibitor. Regulation of Transcription by p21WAF1/CIP1/SDI1 Cell Cycle. 1:2002;39-41.
30. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., Nabel G.J. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275:1997;523-527.
31. Pichler A., Melchior F. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport. Traffic. 3:2002;381-387.
32. Pichler A., Gast A., Seeler J.S., Dejean A., Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell. 108:2002;109-120.
33. Rodriguez M.S., Desterro J.M., Lain S., Midgley C.A., Lane D.P., Hay R.T. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18:1999;6455-6461.
34. Rodriguez M.S., Dargemont C., Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276:2001;12654-12659.
35. Ross S., Best J.L., Zon L.I., Gill G. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization Mol. Cell. 10:2002;831-842.
36. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F., Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15:2001;3088-3103.
37. Sapetschnig A., Rischitor G., Braun H., Doll A., Schergaut M., Melchior F., Suske G. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J. 21:2002;5206-5215.
38. Schmidt D., Muller S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA. 99:2002;2872-2877.
39. Seigneurin-Berny D., Verdel A., Curtet S., Lemercier C., Garin J., Rousseaux S., Khochbin S. Identification of components of the murine histone deacetylase 6 complex. link between acetylation and ubiquitination signaling pathways Mol. Cell. Biol. 21:2001;8035-8044.
40. Snowden A.W., Anderson L.A., Webster G.A., Perkins N.D. A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation. Mol. Cell. Biol. 20:2000;2676-2686.
41. Swope D.L., Mueller C.L., Chrivia J.C. CREB-binding protein activates transcription through multiple domains. J. Biol. Chem. 271:1996;28138-28145.
42. Takahashi Y., Kahyo T., Toh E.A., Yasuda H., Kikuchi Y. Yeast Ull1/Siz1 is a novel SUMO1/Smt3 ligase for septin components and functions as an adaptor between conjugating enzyme and substrates. J. Biol. Chem. 276:2001;48973-48977.
43. Tatham M.H., Jaffray E., Vaughan O.A., Desterro J.M., Botting C.H., Naismith J.H., Hay R.T. Polymeric chains of sumo-2 and sumo-3 are conjugated to protein substrates by sae1/sae2 and ubc9. J. Biol. Chem. 276:2001;35368-35374.
44. VanDemark A.P., Hill C.P. SUMO wrestling with specificity. Structure. 10:2002;281-282.
45. von Mikecz A., Zhang S., Montminy M., Tan E.M., Hemmerich P. CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus. J. Cell Biol. 150:2000;265-273.
46. Webster G.A., Perkins N.D. Transcriptional cross talk between NF-kappaB and p53. Mol. Cell. Biol. 19:1999;3485-3495.
47. Yao T.P., Oh S.P., Fuchs M., Zhou N.D., Ch'ng L.E., Newsome D., Bronson R.T., Li E., Livingston D.M., Eckner R. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell. 93:1998;361-372.